Compromised axon initial segment integrity in EAE is preceded by microglial reactivity and contact.
Academic Article
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
abstract
-
Axonal pathology is a key contributor to long-term disability in multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system (CNS), but the mechanisms that underlie axonal pathology in MS remain elusive. Evidence suggests that axonal pathology is a direct consequence of demyelination, as we and others have shown that the node of Ranvier disassembles following loss of myelin. In contrast to the node of Ranvier, we now show that the axon initial segment (AIS), the axonal domain responsible for action potential initiation, remains intact following cuprizone-induced cortical demyelination. Instead, we find that the AIS is disrupted in the neocortex of mice that develop experimental autoimmune encephalomyelitis (EAE) independent of local demyelination. EAE-induced mice demonstrate profound compromise of AIS integrity with a progressive disruption that corresponds to EAE clinical disease severity and duration, in addition to cortical microglial reactivity. Furthermore, treatment with the drug didox results in attenuation of AIS pathology concomitantly with microglial reversion to a less reactive state. Together, our findings suggest that inflammation, but not demyelination, disrupts AIS integrity and that therapeutic intervention may protect and reverse this pathology. GLIA 2016;64:1190-1209.© 2016 Wiley Periodicals, Inc.
publication date
published in
Research
keywords
-
Animals
-
Animals, Genetically Modified
-
Autoimmune Diseases of the Nervous System
-
Axon Initial Segment
-
Axons
-
CD11b Antigen
-
Cell Death
-
Cells, Cultured
-
Cuprizone
-
Disease Models, Animal
-
Encephalomyelitis, Autoimmune, Experimental
-
Gene Expression Regulation
-
Hydroxamic Acids
-
Macrophage Colony-Stimulating Factor
-
Mice
-
Mice, Inbred C57BL
-
Microglia
-
Monoamine Oxidase Inhibitors
-
Nitric Oxide Synthase Type II
-
Thy-1 Antigens
-
Tumor Necrosis Factor-alpha
Identity
Digital Object Identifier (DOI)
PubMed ID
Additional Document Info
start page
end page
volume
number